A new Israeli fund selected fourteen multidisciplinary research teams to receive $16.6 million to advance the field of precision medicine (personalized medicine). With a trend toward the tailoring of treatment based on the characteristic of a specific patient (or group of similar patients) and a genetic understanding of their disease, the Israeli group is making a timely and calculated investment.

A total of 100 applications for the funding was submitted and only the 14 were selected by the Israel Precision Medicine Partnership (IPMP) administered and operated by the Israel Science Foundation, a non-profit organization supporting breakthrough science research in that nation. Professor Roger Kornberg, of Stanford University, a Nobel Prize laureate in chemistry chaired the selection committee.

Source: Nocamels

Pin It on Pinterest